Market and Future of Therapeutics
Increasing prevalence of allergic conjunctivitis and rhinitis is expected to drive the growth of global allergy treatment drugs market over the forecast period. Several allergy drugs are on the market. There are over-the-counter medications and prescription medications that reduce specific symptoms associated with allergic reactions. Ongoing scientific researches that define the mechanisms involved in allergic reactions will lead to more effective therapeutics and potentially allergy preventions. Treatments like immunotherapies which focus to minimize the reaction itself compared to minimize symptoms associated with the response, will likely be those that lead to full cures or preventions for allergies.
- Probiotics
- Immunotherapies
Related Conference of Market and Future of Therapeutics
21th International Conference on Allergic Diseases and Clinical Immunology
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
Market and Future of Therapeutics Conference Speakers
Recommended Sessions
- Immune Disorders
- Allergic Contact Dermatitis
- Allergic Rhinitis
- Allergy and Inflammation
- Anaphylaxis and Asthma
- Autoimmune Diseases
- Cancer Immunology
- Clinical Immunology
- Coronavirus and SARS-CoV-2
- Developmental Immunology
- Food Allergy and Drug Allergy
- Immune System and Allergic Reactions
- Immunopathology of COVID 19
- Immunotherapy and Behavioural Immunity
- Market and Future of Therapeutics
- Molecular Allergology and Allergy Diagnostics
- Neonatal and Pediatric Immunology
- Oral Allergy Syndrome
- Oral Immunotherapy and Allergen Immunotherapy
- Vaccination and Immunisation
- Veterinary Allergology
Related Journals
Are you interested in
- Adaptive Immunity, Memory Formation & T-Cell Engineering - European Immunology 2026 (France)
- Allergy, Hypersensitivity & Immune Tolerance - Immunology 2026 (France)
- Allergy, Hypersensitivity & Immune Tolerance Strategies - European Immunology 2026 (France)
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Autoimmune & Inflammatory Disorders - Immunology 2026 (France)
- Autoimmunity Mechanisms & Precision Immunoregulation - European Immunology 2026 (France)
- Cancer Immunology & Tumor Microenvironment - Immunology 2026 (France)
- Cellular Signaling & Cell Fate Determination - Immunology 2026 (France)
- Clinical and Translational Immunology - Immunology 2026 (France)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Computational Immunology, AI Modeling & Immune System Simulation - European Immunology 2026 (France)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Cytokine Signaling Networks & Immune Modulation - European Immunology 2026 (France)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Immune Cell Reprogramming & Gene-Edited Immunotherapies - European Immunology 2026 (France)
- Immunogenetics & Epigenetic Regulation - Immunology 2026 (France)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Immunometabolism - Immunology 2026 (France)
- Immunometabolism & Cellular Energy Dynamics - European Immunology 2026 (France)
- Immunotherapy & Immune Modulation - Immunology 2026 (France)
- Infectious Diseases - Antibiotics 2026 (UK)
- Infectious Diseases & Host–Pathogen Interactions - Immunology 2026 (France)
- Inflammation Biology & Chronic Immune Disorders - European Immunology 2026 (France)
- Innate and Adaptive Immune Mechanisms - Immunology 2026 (France)
- Innate Immune Sensors, Pattern Recognition & Host Defense - European Immunology 2026 (France)
- Innovations in Cell Biology & Imaging Technologies - Immunology 2026 (France)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microbiome–Immune Axis & Host Interaction Pathways - European Immunology 2026 (France)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Molecular & Cellular Immunology - Immunology 2026 (France)
- Mucosal Immunity & Barrier Protection Mechanisms - European Immunology 2026 (France)
- Nanotechnology-Enabled Immune Delivery Systems - European Immunology 2026 (France)
- Neuroimmunology & Brain–Immune Interactions - Immunology 2026 (France)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Next-Generation Vaccines & Antigen Engineering - European Immunology 2026 (France)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- Stem Cells & Regenerative Immunology - Immunology 2026 (France)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)
- Tumor Immunology & Personalized Cancer Immunotherapies - European Immunology 2026 (France)
- Vaccines & Vaccine Technology - Immunology 2026 (France)
- Viral Immunology, Emerging Pathogens & Host Response - European Immunology 2026 (France)
